Chunlai Feng
- Molecular Biology
- Biomaterials top 5%
- Biomedical Engineering top 10%
- Pharmacology top 5%
- Pharmaceutical Science top 5%
- Topics
- Nanoparticle-Based Drug Delivery (8 papers)Computational Drug Discovery Methods (7 papers)Metabolomics and Mass Spectrometry Studies (4 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Chunlai Feng
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 538
- Biomaterials 350
- Biomedical Engineering 291
- Pharmacology 123
- Pharmaceutical Science 120
Countries citing papers authored by Chunlai Feng
This map shows the geographic impact of Chunlai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlai Feng more than expected).
Fields of papers citing papers by Chunlai Feng
This network shows the impact of papers produced by Chunlai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlai Feng. The network helps show where Chunlai Feng may publish in the future.
Co-authorship network of co-authors of Chunlai Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Chunlai Feng. A scholar is included among the top collaborators of Chunlai Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlai Feng. Chunlai Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 17 | |
| 5 | 6 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 30 | |
| 10 | 39 | |
| 11 | 39 | |
| 12 | 94 | |
| 13 | 27 | |
| 14 | 4 | |
| 15 | 88 | |
| 16 | 33 | |
| 17 | 43 | |
| 18 | 27 | |
| 19 | 226 | |
| 20 | 23 |
About Chunlai Feng
Chunlai Feng is a scholar working on Pharmacology, Biomaterials and Pharmaceutical Science, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Computational Drug Discovery Methods (7 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). The work is most often cited by research in Biomaterials (350 citations), Pharmaceutical Science (120 citations) and Pharmacology (123 citations). Chunlai Feng has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Mengjie Rui, Ximing Xu, F. Du, Jijin Gu, Yike Xie, Xiaoling Fang, Xinyi Jiang, Hongliang Xin, Qiuyue Ren and Jiangnan Yu. Their work appears in journals such as Advanced Materials, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.